Cybersecurity Threats to Medical Devices: Navigating the Evolving Threat Landscape

by Partha Anbil

This examines the current cybersecurity threat landscape, regulatory evolution, and organizational strategies essential for protecting life-critical medical devices and patient safety in an increasingly interconnected healthcare environment.

The double-edged sword of healthcare connectivity

The digitization of healthcare has revolutionized the delivery of patient care. Connected medical devices—from insulin pumps and cardiac implants to networked infusion pumps and diagnostic imaging systems—enable real-time monitoring, remote adjustments, and seamless data integration into electronic health records. However, this connectivity comes at a high cost: each connected device represents a potential entry point for cyberattacks.

The challenge is particularly acute with Class III medical devices, which sustain or support life and pose the greatest risk to patients if compromised. FDA estimates that 164 out of every 1,000 devices remain vulnerable to cyberattacks [4]. 

While the healthcare industry has made progress in cybersecurity awareness, critical gaps persist. 

A 2025 survey revealed that 73% of healthcare organizations still operate legacy devices with outdated operating systems that lack modern security protection [5]. This technological debt creates cascading vulnerabilities across hospital networks.

The Current Threat Landscape

Ransomware evolution and data extortion

The healthcare sector’s experience with ransomware has fundamentally shifted in 2025-2026. Rather than simply encrypting data and demanding payment for decryption keys, threat actors increasingly employ a dual-extortion model: they steal sensitive patient data before encrypting systems, then extort payments by threatening to officially release this information. 

In 2025, healthcare businesses (including pharmaceutical manufacturers, medical billing providers, and healthcare technology companies) experienced a 30% increase in attacks compared with 2024, driven largely by this shift toward data-theft-based extortion [3]. 

The most prolific ransomware strains targeting healthcare in 2025 included INC (39 attacks), Qilin (34), SafePay (21), RansomHub (13), and Medusa (13), with confirmed breaches involving more than 7.4 million records [3].

IoMT device vulnerabilities at scale

Recent research underscores a fundamental vulnerability challenge: a 2022 FBI report identified that 53% of connected medical devices and other IoT devices had at least one known critical vulnerability that remained unpatched [5]. 

Despite nearly four years of regulatory emphasis on cybersecurity, this statistic remains alarmingly relevant in 2026. The vulnerability problem is compounded by resource constraints and organizational complexity. 

Studies show that on average, it takes approximately 3.2 years from the time a medical device is purchased to the disclosure of vulnerabilities in its components [7]. 

For many hospitals, applying patches is a complex risk-management calculation: firmware updates may require device downtime, creating clinical risks that must be weighed against cybersecurity benefits.

Emerging threat vectors

Security researchers have demonstrated successful attacks against insulin pumps, pacemakers, and implantable cardioverter-defibrillators—showing that attackers could theoretically alter medication dosages, deplete device batteries, or manipulate vital monitoring data [8]. 

While no major patient harm from medical device cyberattacks has been publicly confirmed as of early 2026, the theoretical risk remains substantial. Physical security vulnerabilities have also emerged as a concern. 

Some medical devices permit data access via physical ports without requiring encryption or additional authentication, creating attack vectors that do not require network penetration [5].

Regulatory framework: FDA’s 2025 guidance and section 524B mandate

In June 2025, FDA issued comprehensive final guidance on “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,” consolidating and clarifying cybersecurity requirements that have evolved since 2023 [9]. This guidance makes cybersecurity a mandatory lifecycle obligation for manufacturers, not merely a premarket consideration.

Section 524B of the Food and Drug Administration Reauthorization Act (FDARA), enacted as part of the Consolidated Appropriations Act of 2023, establishes the regulatory backbone for medical device cybersecurity. Key requirements include:

1. Premarket demonstration of cybersecurity: Manufacturers must demonstrate reasonable assurance of cybersecurity through comprehensive documentation [9]

2. Software Bill of Materials (SBOM): Complete disclosure of all software components and dependencies

3. Post-market cybersecurity management: Systematic procedures for identifying and addressing vulnerabilities after-market release.

4. Timely vulnerability disclosure: FDA guidance recommends disclosure of critical vulnerabilities within 30 days of discovery [5]

5. Risk-based update pathways: Classification of risks as either “uncontrolled” (requiring immediate action) or “controlled” (following scheduled maintenance windows) [5]

FDA’s approach has shifted from presumptive judgments to explicit requirements. Previously, manufacturers could argue that devices were designed for a secure IT environment. 

Now, responsibility for maintaining cybersecurity throughout the entire device lifecycle rests primarily with manufacturers, with shared responsibility in the post-market phase between manufacturers and end-users [10]. A critical requirement is that if a subject device demonstrates increased cyber risks relative to a predicate device, FDA may determine that the subject device is not substantially equivalent, thereby requiring more extensive premarket review [9].

The knowledge gap: Clinical teams and cybersecurity awareness

Despite nearly a decade of emphasis on healthcare cybersecurity, a substantial knowledge gap persists among clinical professionals. Research from a 2025 study on nursing perspectives found that nurses, the heaviest users of medical devices in clinical settings, have enormous gaps in formal cybersecurity education, leaving them largely unprepared to recognize or respond to threats [11]. 

A survey of healthcare professionals found that 96% of clinical informaticians view cybersecurity awareness as essential for protecting patient data [12]. 

However, when asked about training, many clinicians reported receiving no formal education on medical device cybersecurity. This disconnect reflects a broader organizational challenge: cybersecurity training has traditionally been developed by IT professionals without clinical expertise, resulting in resources that feel disconnected from clinical realities.

Healthcare organizations making progress on medical device security have implemented integrated teams that include clinical, IT, cybersecurity, procurement, and biomedical engineering personnel. 

These collaborative approaches address critical needs, including informed device procurement decisions, incident response coordination requiring both clinical and technical assessment, tailored training programs using clinical language and scenarios, and continuous monitoring where cybersecurity teams flag suspicious patterns while clinical teams identify normal device behavior. Healthcare leadership must recognize that cybersecurity is fundamentally a patient safety issue, not merely a technical concern.

Post-Market surveillance and the patching challenge

One of the most significant practical challenges facing healthcare organizations is the temporal gap between vulnerability discovery and patch availability. 

FDA’s 2025 guidance recommends that manufacturers disclose vulnerabilities within 30 days of discovery [5]. 

However, the actual timeline from vulnerability identification to the development, testing, and deployment of a patch is often measured in months. 

For critical vulnerabilities that could affect patient safety, healthcare organizations face a risk-management dilemma: deploy patches promptly and accept the risk of clinical disruption or maintain system stability and accept the risk of cybersecurity breaches. 

Some organizations have adopted interim mitigating controls — such as network segmentation, enhanced monitoring, and access restrictions—while awaiting patches.

Current expectations for manufacturers have expanded substantially. 

Beyond providing timely patches, manufacturers are now expected to conduct threat modeling, provide detailed system architecture documentation with data flow diagrams, implement secure-by-design principles, encrypt patient data in transit and at rest, employ multi-factor authentication, provide transparency through updated MDS2 forms, and establish post-market surveillance processes with dedicated resources. 

However, while most large manufacturers have implemented some cybersecurity measures, smaller manufacturers often lack dedicated cybersecurity personnel and resources [10].

Balancing patient safety with device security

Healthcare providers face a fundamental tension: clinical necessity often demands immediate access to medical devices, while security best practices require restricting access and implementing controls that can slow clinical workflows. 

This tension is not purely theoretical. During the 2017 WannaCry ransomware attack on the UK’s National Health Service, hospitals experienced a 9% decline in elective admissions and a 6% decline in general admissions, resulting in a monetary loss of £5.9 million [13].

Recent analysis from the Cynerio and Ponemon Institute’s 2022 study found that healthcare organizations experiencing cyberattacks reported: 56% increase in hospital bed days; 53% rise in patient mortality rates; 47% of surgical procedures and diagnostic tests affected; 37% increase in patient transfers to other facilities; and 28% increase in medical procedure complications [14]. 

While these correlations do not necessarily imply causation, they underscore the clinical impact of cyberattacks on healthcare operations.

About 73% of healthcare organizations operate medical devices with legacy operating systems that no longer receive security patches or updates [5]. These devices often represent millions of dollars in capital investments and may be clinically essential, making wholesale replacement infeasible. 

Healthcare organizations managing legacy devices have adopted several strategies: network segmentation and “air-gapping” to isolate devices from broader networks; enhanced monitoring for anomalous behavior; restricted remote access; physical security measures; accelerated replacement timelines for critical devices; and vendor-funded extended support arrangements.

Emerging solutions and best practices

Healthcare organizations are increasingly implementing artificial intelligence-based security solutions for medical device environments. 

These tools can detect anomalous device behavior in real-time, predict potential vulnerabilities based on threat intelligence, automate routine security scanning and compliance monitoring, and provide contextual analysis distinguishing between normal large data transfers and suspicious activity. 

Several hospitals have reported success with AI-driven IoMT security platforms that maintain continuous visibility of connected devices without requiring modifications to clinical workflows.

Healthcare organizations are also extending cybersecurity requirements upstream to device manufacturers and downstream to healthcare IT vendors. 

This includes requiring Software Bills of Materials (SBOMs) before device purchase, conducting vendor cybersecurity assessments during procurement, establishing service-level agreements that include cybersecurity response timelines, and implementing supply chain monitoring for unauthorized modifications.

Looking forward: The 2026 challenge

As the healthcare industry enters 2026, several critical challenges demand attention: the scale of IoMT deployment exceeding many organizations’ monitoring and management capacity; formalizing cybersecurity education within clinical curricula and continuing education programs; addressing compliance variability among smaller manufacturers; persistent unpatched vulnerabilities in 53% of devices representing ongoing risk; and ensuring interdisciplinary alignment in cybersecurity decision-making.

Conclusion

The cybersecurity threat landscape facing healthcare’s medical device ecosystem has become increasingly sophisticated and consequential. Ransomware operators now employ dual-extortion tactics, targeting both operational networks and stored data. Connected medical devices, while delivering substantial clinical benefits, have exponentially expanded the attack surface. 

However, the response from regulatory agencies, manufacturers, and healthcare organizations has also evolved. FDA’s 2025 guidance provides explicit requirements for cybersecurity throughout the device lifecycle, and healthcare organizations are increasingly implementing integrated cybersecurity governance that includes clinical perspectives.

Progress remains uneven, and significant work lies ahead. The knowledge gaps among clinical professionals persist despite nearly a decade of emphasis on healthcare cybersecurity. 

Approximately 73% of hospitals still operate legacy devices with unpatched vulnerabilities, and smaller manufacturers continue to lag in cybersecurity maturity. Yet the trajectory is clear: cybersecurity will increasingly determine which medical devices succeed in the market. 

Healthcare organizations prioritizing medical device security now will be better positioned to protect patient safety and maintain operational continuity as threats evolve. For industry professionals, the imperative is clear: cybersecurity is no longer a technical concern relegated to IT departments—it is a clinical patient safety issue demanding engagement from every healthcare professional responsible for medical device deployment and use.